KING OF PRUSSIA, Pa., April 29, 2021 /PRNewswire/ — Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Hizentra ...
The prescribed dosage for Hizentra (immune globulin subcutaneous [human]) may vary depending on an individual’s treatment plan. Other factors, including your specific diagnosis, body weight, and ...
Hizentra (immune globulin subcutaneous [human], 20% liquid) is a prescription drug approved to treat certain conditions that affect the immune system. Hizentra comes as a liquid solution given as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results